Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3186540 | 0.97 | SHBG (0.36) | SHBGCYP1A2 | |
| Iodide SCHEMBL20875137 | 0.94 | SHBG (0.35) | SHBGCYP1A2 | |
| Water SCHEMBL3186572 | 0.94 | SHBG (0.35) | SHBGCYP1A2 | |
| Bromide SCHEMBL5393945 | 0.94 | SHBG (0.35) | SHBGCYP1A2 | |
| SCHEMBL16594155 | 0.94 | SHBG (0.32) | SHBGCYP1A2 | |
| Hydrochloric Acid SCHEMBL26107157 | 0.85 | KDM4E (0.33) | — | |
| Sulfuric Acid SCHEMBL31286305 | 0.84 | CA12 (0.34) | — | |
| SCHEMBL15293599 | 0.82 | CYP1A2 (0.34) | SHBGCYP1A2 | |
| SCHEMBL28433253 | 0.82 | CYP1A2 (0.34) | SHBGCYP1A2 | |
| SCHEMBL20796997 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250204164-A1 | DISPLAY DEVICE AND PHOTOSENSITIVE COMPOSITION | TORAY INDUSTRIES, INC. (JP) | 2025-06-19 | — | — | US | disclosed |
| CN-118923228-A | Display device and photosensitive composition | 东丽株式会社 | 2024-11-08 | — | — | CN | disclosed |
| WO-2023190218-A1 | DISPLAY DEVICE AND PHOTOSENSITIVE COMPOSITION | 東レ株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-6841548-B2 | Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives | SCHERING AG (DE) | 2005-01-11 | — | — | US | disclosed |
| US-6569844-B1 | Hormonal contraception and hormon replacement therapy with low hepatic estrogenity | JENAPHARM GMBH & CO., KG (DE) | 2003-05-27 | — | — | US | disclosed |
| US-20020061868-A1 | Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives | STERIX LIMITED (GB) | 2002-05-23 | — | — | US | disclosed |
| CN-1160404-A | Pharmaceutical compositions contg. estra-1,3,5C10-triene derivs. | JENAPHARM GMBH (DE) | 1997-09-24 | — | — | CN | disclosed |
| US-4645817-A | PHASE TRANSFER CATALYSIS; COMPLEXES | BAYER AKTIENGESELLSCHAFT (DE) | 1987-02-24 | — | — | US | disclosed |
| EP-0159643-A2 | Process for the manufacture of alkoxylation products of organic carboxylic acids containing hydroxyl groups. | BAYER AG (DE) | 1985-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061868-A1 | Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives | ESRRA, ESR2, CYP19A1 | SHBG 21/4885CYP1A2 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.